Cytophilic antibodies to Plasmodium falciparum Glutamate Rich Protein are associated with malaria protection in an area of holoendemic transmission

[1] Marsh K(1997)Host-parasite interaction and morbidity in malaria endemic areas Philos Trans R Soc Lond B Biol Sci 352 1385-1394

[2] Snow RW(1998)Malaria and anaemia at different altitudes in the Muheza district of Tanzania: childhood morbidity in relation to level of exposure to infection Ann Trop Med Parasitol 92 741-753

[3] Ellman R(1991)Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria Am J Trop Med Hyg 45 297-308

[4] Maxwell C(1992)Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Parasite Immunol 14 321-337

[5] Finch R(2000) are associated with reduced malaria morbidity Nat Med 6 689-692

[6] Shayo D(2004)A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses Infect Immun 72 247-252

[7] Sabchareon A(1999)Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein Infect Immun 67 2131-2137

[8] Burnouf T(1998)Levels of antibody to conserved parts of Nat Med 4 358-360

[9] Ouattara D(2000) merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria Immunol Lett 71 117-126

[10] Attanath P(1991)Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria Am J Trop Med Hyg 44 306-313

[1] Marsh K(1997)Host-parasite interaction and morbidity in malaria endemic areas Philos Trans R Soc Lond B Biol Sci 352 1385-1394

[2] Snow RW(1998)Malaria and anaemia at different altitudes in the Muheza district of Tanzania: childhood morbidity in relation to level of exposure to infection Ann Trop Med Parasitol 92 741-753

[3] Ellman R(1991)Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria Am J Trop Med Hyg 45 297-308

[4] Maxwell C(1992)Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Parasite Immunol 14 321-337

[5] Finch R(2000) are associated with reduced malaria morbidity Nat Med 6 689-692

[6] Shayo D(2004)A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses Infect Immun 72 247-252

[7] Sabchareon A(1999)Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein Infect Immun 67 2131-2137

[8] Burnouf T(1998)Levels of antibody to conserved parts of Nat Med 4 358-360

[9] Ouattara D(2000) merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria Immunol Lett 71 117-126

[10] Attanath P(1991)Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria Am J Trop Med Hyg 44 306-313